Russell, T.; Rowe, H.; Bridgewood, C.; Cuthbert, R.J.; Watad, A.; Newton, D.; Jones, E.; McGonagle, D.
Tofacitinib Blocks Entheseal Lymphocyte Activation and Modulates MSC Adipogenesis, but Does Not Directly Affect Chondro- and Osteogenesis. Immuno 2021, 1, 545-557.
https://doi.org/10.3390/immuno1040038
AMA Style
Russell T, Rowe H, Bridgewood C, Cuthbert RJ, Watad A, Newton D, Jones E, McGonagle D.
Tofacitinib Blocks Entheseal Lymphocyte Activation and Modulates MSC Adipogenesis, but Does Not Directly Affect Chondro- and Osteogenesis. Immuno. 2021; 1(4):545-557.
https://doi.org/10.3390/immuno1040038
Chicago/Turabian Style
Russell, Tobias, Hannah Rowe, Charlie Bridgewood, Richard J. Cuthbert, Abdulla Watad, Darren Newton, Elena Jones, and Dennis McGonagle.
2021. "Tofacitinib Blocks Entheseal Lymphocyte Activation and Modulates MSC Adipogenesis, but Does Not Directly Affect Chondro- and Osteogenesis" Immuno 1, no. 4: 545-557.
https://doi.org/10.3390/immuno1040038
APA Style
Russell, T., Rowe, H., Bridgewood, C., Cuthbert, R. J., Watad, A., Newton, D., Jones, E., & McGonagle, D.
(2021). Tofacitinib Blocks Entheseal Lymphocyte Activation and Modulates MSC Adipogenesis, but Does Not Directly Affect Chondro- and Osteogenesis. Immuno, 1(4), 545-557.
https://doi.org/10.3390/immuno1040038
